Skip to main content
Screener/Healthcare/Biotechnology

ALLO — Allogene Therapeutics, Inc.

NASDAQ
$2.27+0.01 (+0.22%)
Small CapPenny StockUnder $5Healthcare
$0.86
$4.46
$2.25
$2.36
EPS (TTM)$-0.87
P/E Ratio-2.53
Dividend Yield—
Market Cap$551.1M
Volume3.64M
Prev Close$2.27
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$38.8M$-0.17——
Q3 '25$0-$41.4M$-0.19——
Q2 '25$0-$50.9M$-0.23——
Q1 '25$0-$59.7M$-0.28——
Q4 '24$0-$59.9M$-0.28——
Q3 '24$0-$66.3M$-0.32——
Q2 '24$0-$66.4M$-0.35——
Q1 '24$22K-$65.0M$-0.38-16059.1%-295454.5%
Get Your Daily Market Recap